Selective in situ protein expression profiles correlate with distinct phenotypes of basal cell carcinoma and squamous cell carcinoma of the skin

Histology and Histopathology

Volumn 28, Issue 7, 2013, Pages 941-954

  Stelkovics, E ^a   Kiszner, G ^b   Meggyeshazi, N ^b   Korom, I ^c   Varga, E ^c   Nemeth, I ^c   Molnar, J ^c   Marczinovits, I ^c   Krenacs, Tibor ^b  

^a BAY ZOLTÁN NONPROFIT LTD FOR APPLIED RESEARCH   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Basal cell carcinoma; Differential protein expression; Hierarchical cluster analysis; Skin cancer; Squamous cell carcinoma; Tissue microarray

Indexed keywords

CASP8 PROTEIN, HUMAN; CASP9 PROTEIN, HUMAN; CASPASE 8; CASPASE 9; COLLAGEN; CONNEXIN 43; EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; AGED; APOPTOSIS; ARTICLE; BASAL CELL CARCINOMA; BIOPSY; CLUSTER ANALYSIS; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; MALE; METABOLISM; MIDDLE AGED; PHENOTYPE; SKIN; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; BIOPSY; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CASPASE 8; CASPASE 9; CLUSTER ANALYSIS; COLLAGEN; CONNEXIN 43; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; RECEPTOR, EPIDERMAL GROWTH FACTOR; SKIN; SKIN NEOPLASMS;

EID: 84879778821     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Abd Elmageed Z.Y., Gaur R.L., Williams M., Abdraboh M.E., Rao P.N., Raj M.H., Ismail F.M. and Ouhtit A. (2009). Characterization of coordinated immediate responses by p16INK4A and p53 pathways in UVB-irradiated human skin cells. J. Invest. Dermatol. 129, 175-183.
2. Ansai S.I., Takayama R., Kimura T. and Kawana S. (2012). Ber-EP4 is a useful marker for follicular germinative cell differentiation of cutaneous epithelial neoplasms. J. Dermatol. 117, 59-66.
3. Bachmann F., Buechner S.A., Wernli M., Strebel S. and Erb P. (2001). Ultraviolet light downregulates CD95 ligand and TRAIL receptor expression facilitating actinic keratosis and squamous cell carcinoma formation. J. Invest. Dermatol. 117, 59-66.
4. Backvall H., Asplund A., Gustafsson A., Sivertsson A., Lundeberg J. and Ponten F. (2005). Genetic tumor archeology: microdissection and genetic heterogeneity in squamous and basal cell carcinoma. Mutat. Res. 571, 65-79.
5. Bosch F.X., Andl C., Abel U. and Kartenbeck J. (2005). E-cadherin is a selective and strongly dominant prognostic factor in squamous cell carcinoma: a comparison of E-cadherin with desmosomal components. Int. J. Cancer 114, 779-790.
6. Boukamp P. (2005). Non-melanoma skin cancer: what drives tumor development and progression? Carcinogenesis 26, 1657-1667.
7. Brennan D. and Mahoney M.G. (2009). Increased expression of Dsg2 in malignant skin carcinomas: A tissue-microarray based study. Cell Adh. Migr. 3, 148-154.
8. Brown V.L., Harwood C.A., Crook T., Cronin J.G., Kelsell D.P. and Proby C.M. (2004). p16INK4a and p14ARF tumor suppressor genes are commonly inactivated in cutaneous squamous cell carcinoma. J. Invest. Dermatol. 122, 1284-1292.
9. Cassarino D.S., Derienzo D.P. and Barr R.J. (2006). Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification--part two. J. Cutan. Pathol. 33, 261-279
10. Cherpelis B.S., Marcusen C. and Lang P.G. (2002). Prognostic factors for metastasis in squamous cell carcinoma of the skin. Dermatol, Surg, 28, 268-273.
11. Christenson L.J., Borrowman T.A., Vachon C.M., Tollefson M.M., Otley C.C., Weaver A.L. and Roenigk R.K. (2005). Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. JAMA 294, 681-690.
12. Conscience I., Jovenin N., Coissard C., Lorenzato M., Durlach A., Grange F., Birembaut P., Clavel C. and Bernard P. (2006). P16 is overexpressed in cutaneous carcinomas located on sun-exposed areas. Eur. J. Dermatol. 16, 518-522.
13. Di Cunto F., Topley G., Calautti E., Hsiao J., Ong L., Seth P.K. and Dotto G.P. (1998). Inhibitory function of p21Cip1/WAF1 in differentiation of primary mouse keratinocytes independent of cell cycle control. Science 280, 1069-1072.
14. Eicheler W., Zips D., Dorfler A., Grenman R. and Baumann M. (2002). Splicing mutations in TP53 in human squamous cell carcinoma lines influence immunohistochemical detection. J. Histochem. Cytochem. 50, 197-204.
15. Eisen M.B., Spellman P.T., Brown P.O. and Botstein D. (1998). Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 95, 14863-14868.
16. Epstein E.H. (2008). Basal cell carcinomas: attack of the hedgehog. Nat. Rev. Cancer 8, 743-754.
17. Erb P., Ji J., Wernli M., Kump E., Glaser A. and Buchner S.A. (2005). Role of apoptosis in basal cell and squamous cell carcinoma formation. Immunol. Lett. 100, 68-72.
18. Greinert R. (2009). Skin cancer: new markers for better prevention. Pathobiology 76, 64-81.
19. Haass N.K., Wladykowski E., Kief S., Moll I. and Brandner J.M. (2006). Differential induction of connexins 26 and 30 in skin tumors and their adjacent epidermis. J. Histochem. Cytochem. 54, 171-182.
20. Hande K.R. (1998). Clinical applications of anticancer drugs targeted to topoisomerase II. Biochim. Biophys. Acta 1400, 173-184.
21. Heaphy M.R. Jr and Ackerman A.B. (2000). The nature of solar keratosis: a critical review in historical perspective. J. Am. Acad. Dermatol. 43, 138-150.
22. Hodges A. and Smoller B.R. (2002). Immunohistochemical comparison of p16 expression in actinic keratoses and squamous cell carcinomas of the skin. Mod. Pathol. 15, 1121-1125.
23. Karvinen S., Kosma V.M., Tammi M.I. and Tammi R. (2003). Hyaluronan, CD44 and versican in epidermal keratinocyte tumours. Br. J. Dermatol. 148, 86-94.
24. Kononen J., Bubendorf L., Kallioniemi A., Barlund M., Schraml P., Leighton S., Torhorst J., Mihatsch M.J., Sauter G. and Kallioniemi O.P. (1998). Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat. Med. 4, 844-847.
25. Kovalenko A., Kim J.C., Kang T.B., Rajput A., Bogdanov K., Dittrich-Breiholz O., Kracht M., Brenner O. and Wallach D. (2009). Caspase-8 deficiency in epidermal keratinocytes triggers an inflammatory skin disease. J. Exp. Med. 206, 2161-2177.
26. Krenacs T., Ficsor L., Varga S.V., Angeli V. and Molnar B. (2010). Digital microscopy for boosting database integration and analysis in TMA studies. Methods Mol. Biol. 664, 163-175.
27. Krunic A.L., Garrod D.R., Madani S., Buchanan M.D. and Clark R.E. (1998). Immunohistochemical staining for desmogleins 1 and 2 in keratinocytic neoplasms with squamous phenotype: actinic keratosis, keratoacanthoma and squamous cell carcinoma of the skin. Br. J. Cancer 77, 1275-1279.
28. Kudo Y., Kitajima S., Ogawa I., Hiraoka M., Sargolzaei S., Keikhaee M.R., Sato S., Miyauchi M. and Takata T. (2004). Invasion and metastasis of oral cancer cells require methylation of E-cadherin and/or degradation of membranous beta-catenin. Clin. Cancer Res. 10, 5455-5463
29. Kurzen H., Munzing I. and Hartschuh W. (2003). Expression of desmosomal proteins in squamous cell carcinomas of the skin. J. Cutan. Pathol. 30, 621-630
30. Kutting B. and Drexler H. (2010). UV-induced skin cancer at workplace and evidence-based prevention. Int. Arch. Occup. Environ Health 83, 843-854.
31. LeBoit P.E., Burg G., Weedon D. and Sarasin A. (2006). Keratinocytic tumours. In: Pathology and genetics of skin tumours. World Health Organization Classification of Tumours. IARC Press. Lyon. pp 9-47.
32. Lee P., Lee D.J., Chan C., Chen S.W., Ch'en I. and Jamora C. (2009). Dynamic expression of epidermal caspase 8 simulates a wound healing response. Nature 458, 519-523.
33. Liu C.L., Prapong W., Natkunam Y., Alizadeh A., Montgomery K., Gilks C.B. and van de Rijn M. (2002). Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays. Am. J. Pathol. 161, 1557-1565.
34. Lomas A., Leonardi-Bee J. and Bath-Hextall F. (2012). A systematic review of worldwide incidence of nonmelanoma skin cancer. Br. J. Dermatol 166, 1069-1080.
35. Lyakhovitsky A., Barzilai A., Fogel M., Trau H. and Huszar M. (2004). Expression of e-cadherin and beta-catenin in cutaneous squamous cell carcinoma and its precursors. Am. J. Dermatopathol 26, 372-378.
36. Marks R., Rennie G. and Selwood T.S. (1988). Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet 1, 795-797
37. Mineta H., Borg A., Dictor M., Wahlberg P., Akervall J. and Wennerberg J. (1998). p53 mutation, but not p53 overexpression, correlates with survival in head and neck squamous cell carcinoma. Br. J. Cancer 78, 1084-1090.
38. Moy R.L., Eliezri Y.D., Nuovo G.J., Zitelli J.A., Bennett R.G. and Silverstein S. (1989). Human papillomavirus type 16 DNA in periungual squamous cell carcinomas. JAMA 261, 2669-2673.
39. Naus C.C. and Laird D.W. (2009). Implications and challenges of connexin connections to cancer. Nat. Rev. Cancer 10, 435-441.
40. Nilsson K., Svensson S. and Landberg G. (2004). Retinoblastoma protein function and p16INK4a expression in actinic keratosis, squamous cell carcinoma in situ and invasive squamous cell carcinoma of the skin and links between p16INK4a expression and infiltrative behavior. Mod. Pathol. 17, 1464-1474.
41. Papadavid E., Pignatelli M., Zakynthinos S., Krausz T. and Chu A.C. (2002). Abnormal immunoreactivity of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex in premalignant and malignant non-melanocytic skin tumours. J. Pathol. 196, 154-162.
42. Prieto V.G., Reed J.A., McNutt N.S., Bogdany J.K., Lugo J. and Shea C.R. (1995). Differential expression of CD44 in malignant cutaneous epithelial neoplasms. Am. J. Dermatopathol. 17, 447-451.
43. Rangwala S. and Tsai K.Y. (2011). Roles of the immune system in skin cancer. Br. J. Dermatol. 165, 953-965.
44. Rehman I., Takata M., Wu Y.Y. and Rees J.L. (1996). Genetic change in actinic keratoses. Oncogene 12, 2483-2490.
45. Reis-Filho J.S., Torio B., Albergaria A. and Schmitt F.C. (2002). p63 expression in normal skin and usual cutaneous carcinomas. J. Cutan. Pathol. 29, 517-523.
46. Rittie L., Kansra S., Stoll S.W., Li Y., Gudjonsson J.E., Shao Y., Michael L.E., Fisher G.J., Johnson T.M. and Elder J.T. (2007). Differential ErbB1 signaling in squamous cell versus basal cell carcinoma of the skin. Am. J. Pathol. 170, 2089-2099.
47. Rojas P., Cadenas M.B., Lin P.C., Benavides F., Conti C.J. and Rodriguez-Puebla M.L. (2007). Cyclin D2 and cyclin D3 play opposite roles in mouse skin carcinogenesis. Oncogene 26, 1723-1730.
48. Salama M.E., Mahmood M.N., Qureshi H.S., Ma C., Zarbo R.J. and Ormsby A.H. (2003). p16INK4a expression in actinic keratosis and Bowen's disease. Br. J. Dermatol. 149, 1006-1012.
49. Sandri M.I., Isaacs R.J., Ongkeko W.M., Harris A.L., Hickson I.D., Broggini M. and Vikhanskaya F. (1996). p53 regulates the minimal promoter of the human topoisomerase IIalpha gene. Nucleic Acids Res. 24, 4464-4470.
50. Scott C.A., Tattersall D., O'Toole E.A. and Kelsell D.P. (2012). Connexins in epidermal homeostasis and skin disease. Biochim. Biophys. Acta 1818, 1952-1961.
51. Sellheyer K. and Krahl D. (2008). Basal cell (trichoblastic) carcinoma common expression pattern for epithelial cell adhesion molecule links basal cell carcinoma to early follicular embryogenesis, secondary hair germ, and outer root sheath of the vellus hair follicle: A clue to the adnexal nature of basal cell carcinoma? J. Am. Acad. Dermatol. 58, 158-167.
52. Stelkovics E., Korom I., Marczinovits I., Molnar J., Rasky K., Raso E., Ficsor L., Molnar B., Kopper L. and Krenacs T. (2008). Collagen XVII/BP180 protein expression in squamous cell carcinoma of the skin detected with novel monoclonal antibodies in archived tissues using tissue microarrays and digital microscopy. Appl. Immunohistochem. Mol. Morphol. 16, 433-441.
53. Tada J. and Hashimoto K. (1997). Ultrastructural localization of gap junction protein connexin 43 in normal human skin, basal cell carcinoma, and squamous cell carcinoma. J. Cutan. Pathol. 24, 628-635.
54. Tada H., Hatoko M., Tanaka A., Kuwahara M. and Muramatsu T. (2000). Expression of desmoglein I and plakoglobin in skin carcinomas. J. Cutan. Pathol. 27, 24-29.
55. Tanaka N., Odajima T., Ogi K., Ikeda T. and Satoh M. (2003). Expression of E-cadherin, alpha-catenin, and beta-catenin in the process of lymph node metastasis in oral squamous cell carcinoma. Br. J. Cancer 89, 557-563
56. Tilli C.M., Stavast-Koey A.J., Ramaekers F.C. and Neumann H.A. (2002). Bax expression and growth behavior of basal cell carcinomas. J. Cutan. Pathol. 29, 79-87.
57. Tron V.A., Tang L., Yong W.P. and Trotter M.J. (1996). Differentiationassociated overexpression of the cyclin-dependent kinase inhibitor p21waf-1 in human cutaneous squamous cell carcinoma. Am. J. Pathol. 149, 1139-1146.
58. Tsai K.Y. and Tsao H. (2004). The genetics of skin cancer. Am J Med Genet. C Semin. Med. Genet. 131C, 82-92.
59. Uribe P. and Gonzalez S. (2011). Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: molecular bases for EGFR-targeted therapy. Pathol. Res. Pract. 207, 337-342.
60. Utikal J., Udart M., Leiter U., Kaskel P., Peter R.U. and Krahn G. (2005). Numerical abnormalities of the Cyclin D1 gene locus on chromosome 11q13 in non-melanoma skin cancer. Cancer Lett. 219, 197-204
61. von Domarus H. and Stevens P.J. (1984). Metastatic basal cell carcinoma. Report of five cases and review of 170 cases in the literature. J. Am. Acad. Dermatol. 10, 1043-1060
62. Waring A.J., Takata M., Rehman I. and Rees J.L. (1996). Loss of heterozygosity analysis of keratoacanthoma reveals multiple differences from cutaneous squamous cell carcinoma. Br. J. Cancer 73, 649-653.
63. Wrone-Smith T., Bergstrom J., Quevedo M.E., Reddy V., Gutierrez-Steil C. and Nickoloff B.J. (1999). Differential expression of cell survival and cell cycle regulatory proteins in cutaneous squamoproliferative lesions. J. Dermatol. Sci. 19, 53-67.